1. Home
  2. TSBX vs NCI Comparison

TSBX vs NCI Comparison

Compare TSBX & NCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • NCI
  • Stock Information
  • Founded
  • TSBX 2015
  • NCI 1992
  • Country
  • TSBX United States
  • NCI Hong Kong
  • Employees
  • TSBX N/A
  • NCI N/A
  • Industry
  • TSBX
  • NCI
  • Sector
  • TSBX
  • NCI
  • Exchange
  • TSBX Nasdaq
  • NCI NYSE
  • Market Cap
  • TSBX 7.7M
  • NCI 7.4M
  • IPO Year
  • TSBX 2023
  • NCI 2024
  • Fundamental
  • Price
  • TSBX $0.36
  • NCI $2.47
  • Analyst Decision
  • TSBX Buy
  • NCI
  • Analyst Count
  • TSBX 3
  • NCI 0
  • Target Price
  • TSBX $4.75
  • NCI N/A
  • AVG Volume (30 Days)
  • TSBX 706.4K
  • NCI 156.8K
  • Earning Date
  • TSBX 08-13-2025
  • NCI 07-07-2025
  • Dividend Yield
  • TSBX N/A
  • NCI N/A
  • EPS Growth
  • TSBX N/A
  • NCI 67.70
  • EPS
  • TSBX N/A
  • NCI 0.26
  • Revenue
  • TSBX N/A
  • NCI $30,340,230.00
  • Revenue This Year
  • TSBX N/A
  • NCI N/A
  • Revenue Next Year
  • TSBX N/A
  • NCI N/A
  • P/E Ratio
  • TSBX N/A
  • NCI $9.75
  • Revenue Growth
  • TSBX N/A
  • NCI 35.28
  • 52 Week Low
  • TSBX $0.29
  • NCI $1.40
  • 52 Week High
  • TSBX $3.00
  • NCI $9.00
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 44.06
  • NCI N/A
  • Support Level
  • TSBX $0.35
  • NCI N/A
  • Resistance Level
  • TSBX $0.38
  • NCI N/A
  • Average True Range (ATR)
  • TSBX 0.03
  • NCI 0.00
  • MACD
  • TSBX -0.00
  • NCI 0.00
  • Stochastic Oscillator
  • TSBX 3.67
  • NCI 0.00

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About NCI NEO-CONCEPT INTL GRP HLDGS LTD

Neo-Concept International Group Holdings Ltd is a company that is a one-stop apparel solution services provider. The company offers a full suite of services in the apparel supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management serving customers located in the European and North American markets.

Share on Social Networks: